Zinc / Catalase Cancer Research Results

Z, Zinc: Click to Expand ⟱

Features:

Zinc (Zn²⁺) — essential trace element; structural/catalytic cofactor for >300 enzymes and ~10% of the human proteome (zinc-finger transcription factors). Obtained from diet/supplements (e.g., zinc gluconate, acetate, sulfate).

Primary mechanisms (conceptual rank):
1) Metalloprotein cofactor / transcriptional regulation (zinc-finger domains; p53 structural integrity)
2) Redox buffering & signaling modulation (indirect antioxidant; NADPH oxidase/SOD context)
3) Immune regulation (T-cell function; cytokine tone)
4) Apoptosis / mitochondrial signaling (dose-dependent)
5) Synaptic neuromodulation (brain Zn²⁺ pools; excitability)

Bioavailability / PK relevance: Tight homeostatic control (ZIP/ZnT transporters; metallothioneins). Oral absorption varies with form and dietary phytates; systemic free Zn²⁺ remains low (nanomolar). Many in-vitro cytotoxic effects use supra-physiologic micromolar levels.

In-vitro vs oral exposure: Direct tumor cytotoxicity typically at high concentrations (qualifier: high concentration only). Physiologic supplementation mainly corrects deficiency.

Clinical evidence status: Established for deficiency and immune support; oncology data mixed/observational; no stand-alone anti-cancer approval.

Zinc is an essential mineral that supports immune function, wound healing, skin health, and more.

Zinc is an essential cofactor for many enzymes, including superoxide dismutase (SOD), which scavenges free radicals and limits oxidative stress—a known contributor to DNA damage and cancer initiation.

Maintaining adequate zinc status (typically, serum concentrations within a normal reference range of roughly 70–120 µg/dL) is important for overall health, while both deficiency and excessive intake may have implications for cancer risk.

Some zinc-dependent enzymes, such as histone deacetylases (HDACs) or components of chromatin remodeling complexes, rely on zinc for their function.

Zinc can modulate several intracellular signaling cascades. For example, zinc ions may affect the activity of protein kinases and phosphatases.

Evidence suggests that alterations in zinc levels can impact growth factor signaling pathways, which are vital in controlling cell growth and survival and are often dysregulated in cancer.

Zinc is involved in the regulation of cell cycle progression and apoptosis (programmed cell death). It can modulate the activity of several transcription factors (e.g., p53) that regulate growth arrest and apoptosis in response to cellular stress.

Zinc (Zn²⁺) — Cancer vs Normal Cell Pathway Map

Rank	Pathway / Axis	Cancer Cells	Normal Cells	TSF	Primary Effect	Notes / Interpretation
1	p53 structural integrity (zinc-finger stabilization)	↑ (if WT p53; context-dependent)	↑	R/G	Tumor suppressor function support	Zinc required for proper p53 conformation; deficiency impairs DNA damage response.
2	ROS	↓ (physiologic); ↑ (high concentration only)	↓	P/R	Redox modulation	Indirect antioxidant via metallothionein/SOD; excess Zn²⁺ can induce oxidative stress.
3	NRF2 axis	↑ (mild; context-dependent)	↑	R/G	Stress-response activation	Zinc can induce metallothionein and antioxidant gene expression.
4	Apoptosis (mitochondrial; caspases)	↑ or ↓ (dose-dependent)	↔ / ↑ (excess)	R/G	Cell death modulation	Low physiologic levels protective; high intracellular Zn²⁺ may trigger apoptosis.
5	Immune signaling (NF-κB; cytokines)	↓ inflammatory tone (indirect)	↓ (balanced immune support)	R/G	Immune modulation	Deficiency elevates inflammation; repletion normalizes cytokine signaling.
6	PI3K/AKT	↔ / ↑ (context-dependent)	↔	R/G	Growth signaling influence	Zinc transporters (ZIP4, ZIP6) implicated in tumor progression; effect is transporter-context specific.
7	HIF-1α	↓ (some models)	↔	G	Hypoxia signaling modulation	Reported inhibitory interaction in certain tumor models.
8	Ferroptosis	↔ (limited evidence)	↔	R/G	Not primary axis	Indirect influence via redox state possible but not canonical driver.
9	Ca²⁺ signaling	↔ / competitive modulation	↔	P/R	Ion channel interaction	Zinc can modulate NMDA and other channels; more relevant in neurons than oncology.
10	Clinical Translation Constraint	↓ (constraint)	↓ (constraint)	—	Tight homeostasis	Systemic Zn²⁺ tightly regulated; excess supplementation may cause copper deficiency and immune imbalance.

TSF legend:
P: 0–30 min (ion-channel/redox interactions)
R: 30 min–3 hr (signaling modulation)
G: >3 hr (gene-regulatory/phenotype outcomes)

AD relevance: Zinc plays a dual role in Alzheimer’s disease: essential for synaptic function and antioxidant defense, but dysregulated Zn²⁺ can promote amyloid aggregation and excitotoxic injury.

Primary mechanisms (conceptual rank):
1) Aβ aggregation modulation (Zn²⁺ binding to amyloid)
2) Synaptic Zn²⁺ signaling (NMDA modulation; plasticity)
3) Redox buffering (metallothionein induction)
4) Neuroinflammation modulation
5) Tau phosphorylation influence (indirect)

Clinical evidence status: Mixed; deficiency harmful, excess potentially detrimental. No consensus that supplementation benefits established AD unless deficient.

Zinc (Zn²⁺) — AD / Neurodegeneration Pathway Map

Rank	Pathway / Axis	Cells	TSF	Primary Effect	Notes / Interpretation
1	Aβ aggregation	↑ (excess); ↔ (physiologic)	G	Plaque stabilization potential	Zinc binds Aβ; high synaptic Zn²⁺ may promote aggregation.
2	Synaptic transmission (NMDA modulation)	↔ / modulated	P/R	Plasticity regulation	Vesicular Zn²⁺ co-released with glutamate; influences excitability.
3	ROS	↓ (physiologic); ↑ (excess)	P/R	Redox balance	Deficiency increases oxidative stress; overload promotes injury.
4	NRF2 / Metallothionein	↑ (adaptive)	R/G	Antioxidant defense	Metallothioneins buffer Zn²⁺ and reduce oxidative damage.
5	Neuroinflammation	↔ / ↓ (deficiency correction)	R/G	Immune balance	Optimal zinc supports immune regulation; imbalance may exacerbate inflammation.
6	Ca²⁺ excitotoxicity interplay	↔ / ↑ (excess)	P/R	Excitotoxic vulnerability	High Zn²⁺ can enter neurons and impair mitochondrial function.
7	Clinical Translation Constraint	↓ (constraint)	—	Homeostatic narrow range	Both deficiency and excess harmful; supplementation appropriate only if low.

TSF legend:
P: 0–30 min (synaptic ion effects)
R: 30 min–3 hr (signaling adaptation)
G: >3 hr (aggregation and phenotype changes)

Catalase, Catalase: Click to Expand ⟱

Source:

Type:

Caspases are a cysteine protease that speed up a chemical reaction via pointing their target substrates following an aspartic acid residue.1 They are grouped into apoptotic (caspase-2, 3, 6, 7, 8, 9 and 10) and inflammatory (caspase-1, 4, 5, 11 and 12) mediated caspases.
Caspase-1 may have both tumorigenic or antitumorigenic effects on cancer development and progression, but it depends on the type of inflammasome, methodology, and cancer.
Catalase is an enzyme found in nearly all living cells exposed to oxygen. Its primary role is to protect cells from oxidative damage by catalyzing the conversion of hydrogen peroxide (H₂O₂), a potentially damaging byproduct of metabolism, into water (H₂O) and oxygen (O₂). This detoxification process is crucial because excess H₂O₂ can lead to the formation of reactive oxygen species (ROS) that damage proteins, lipids, and DNA.

Catalase and Cancer
Oxidative Stress and Cancer:
Cancer cells often experience increased levels of oxidative stress due to rapid proliferation and metabolic changes. This stress can lead to DNA damage, promoting tumorigenesis.
Catalase helps mitigate oxidative stress, and its expression can influence the survival and proliferation of cancer cells.
Expression Levels in Different Cancers:
Overexpression: In some cancers, such as breast cancer and certain types of leukemia, catalase may be overexpressed. This overexpression can help cancer cells survive in oxidative environments, potentially leading to more aggressive tumor behavior.
Downregulation: Conversely, in other cancers, such as colorectal cancer, reduced catalase expression has been observed. This downregulation can lead to increased oxidative stress, contributing to tumor progression and metastasis.
Prognostic Implications:
Survival Rates: Studies have shown that high levels of catalase expression can be associated with poor prognosis in certain cancers, as it may enable cancer cells to resist apoptosis (programmed cell death) induced by oxidative stress.

Some types of cancer cells have been reported to exhibit lower catalase activity, possibly increasing their vulnerability to oxidative damage under certain conditions. This vulnerability has even been exploited in some therapeutic strategies (for example, approaches that generate excess H₂O₂ or other ROS specifically targeting cancer cells have been researched).

Scientific Papers found: Click to Expand⟱

1407-

GoldNP,

The antioxidant effects of silver, gold, and zinc oxide nanoparticles on male mice in in vivo condition

in-vivo,

NA,

mice

ROS↑, GPx↓, Catalase↓,

Showing Research Papers: 1 to 1 of 1

* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 1

Pathway results for Effect on Cancer / Diseased Cells:

Redox & Oxidative Stress ⓘ

Catalase↓, 1, GPx↓, 1, ROS↑, 1,
Total Targets: 3

Pathway results for Effect on Normal Cells:

Total Targets: 0

Scientific Paper Hit Count for: Catalase, Catalase

Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include : 
  -low or high Dose
  -format for product, such as nano of lipid formations
  -different cell line effects
  -synergies with other products 
  -if effect was for normal or cancerous cells